Cardiomyopeptidin
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Cardiomyopeptidin, covering 2019-05-22 to 2025-05-22. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI [Phase 4]